Possible inhibitory effect of erythropoiesis-stimulating agents at the predialysis stage on early-phase coronary events after hemodialysis initiation (vol 7, pg 21, 2017)

Nishimura, M

CardioRenal Medicine, 2017; 7 (1): 83